Vanguard National Trust
IDXX icon

Vanguard National Trust’s Idexx Laboratories IDXX Stock Holding History

Vanguard National Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
201
+200
+20,000% +$112K 0.01% 339
2026
Q1 		$562 Buy
+1
New +$641 ﹤0.01% 732

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard National Trust's IDXX Position: Q2 2026 in Review

Vanguard National Trust increased its Idexx Laboratories (IDXX) stake by 20,000% in Q2 2026, buying an estimated $112K and bringing the position to 201 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #339.

Vanguard National Trust first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. 1,286 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Vanguard National Trust held 201 shares of Idexx Laboratories worth $106K as of Q2 2026.
  • Vanguard National Trust bought 200 Idexx Laboratories shares in Q2 2026, an estimated $112K.
  • Idexx Laboratories made up 0.01% of Vanguard National Trust's portfolio in Q2 2026, its #339 holding.
  • Vanguard National Trust first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 1,286 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.